Mary MacPartlin

Kinase Domain Mutants of Bcr-Abl Exhibit Altered Transformation Potency, Kinase Activity, and Substrate Utilization, Irrespective of Sensitivity to Imatinib

Ian J. Griswold, Mary MacPartlin, Thomas G.P. Bumm et al. · Molecular and Cellular Biology · 2006 · 199 citations · Full text

Medicine, Molecular Biology, Oncology +13

A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib

Shannon K. McWeeney, Lucy Pemberton, Marc Loriaux et al. · Blood · 2009 · 129 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

A β-catenin/TCF-coordinated chromatin loop at <i>MYC</i> integrates 5′ and 3′ Wnt responsive enhancers

Gregory S. Yochum, Colette M. Sherrick, Mary MacPartlin et al. · Proceedings of the National Academy of Sciences · 2009 · 95 citations · Full text

Medicine, Genetics, Oncology +16

p300 Regulates p63 Transcriptional Activity

Mary MacPartlin, Shelya X. Zeng, Hunjoo Lee et al. · Journal of Biological Chemistry · 2005 · 48 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +14

Phosphorylation and Stabilization of TAp63γ by IκB Kinase-β

Mary MacPartlin, Shelya X. Zeng, Hua Lu · Journal of Biological Chemistry · 2008 · 22 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +6